BioMark Diagnostics Inc.
BUX
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -74.01% | -79.44% | -21.92% | 117.67% | 139.64% |
| Total Receivables | 37.05% | 122.77% | 22.70% | 25.20% | 120.25% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -40.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -61.53% | -53.19% | -24.07% | 58.09% | 104.98% |
|
|
|||||
| Total Current Assets | -61.53% | -53.19% | -24.07% | 58.09% | 104.98% |
| Net Property, Plant & Equipment | -34.41% | 86.62% | 58.67% | 44.60% | 41.03% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 119.44% | 138.68% | 131.48% | 137.74% | -- |
| Total Assets | -40.36% | 39.02% | 34.70% | 48.60% | 56.32% |
|
|
|||||
| Total Accounts Payable | 433.23% | 41.32% | -36.45% | -34.42% | 24.50% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 4.24% | -19.47% | -32.88% | -30.02% | -14.75% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -80.78% | -33.81% | -4.55% | -6.85% | 35.77% |
| Total Finance Division Other Current Liabilities | -7.94% | -7.46% | -10.29% | -19.48% | -5.97% |
| Total Other Current Liabilities | -7.94% | -7.46% | -10.29% | -19.48% | -5.97% |
| Total Current Liabilities | 2.42% | -10.88% | -27.73% | -25.30% | -0.87% |
|
|
|||||
| Total Current Liabilities | 2.42% | -10.88% | -27.73% | -25.30% | -0.87% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 4.24% | -19.47% | -32.88% | -30.02% | -14.75% |
| Capital Leases | -23.73% | 211.58% | 112.27% | 108.71% | 122.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -5.06% | 7.32% | -14.03% | -9.82% | 11.48% |
|
|
|||||
| Common Stock & APIC | -2.90% | 25.49% | 20.60% | 19.20% | 22.41% |
| Retained Earnings | -7.89% | -19.26% | -12.92% | -12.20% | -16.61% |
| Treasury Stock & Other | -- | -15.37% | -6.60% | -2.34% | -- |
| Total Common Equity | -80.00% | 10.08% | 44.91% | 47.01% | 34.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -80.00% | 10.08% | 44.91% | 47.01% | 34.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -80.00% | 10.08% | 44.91% | 47.01% | 34.07% |
|
|
|||||